Tundra Space

Tundra Space

Book DemoDirectoryLog InSign Up

Clinical Research Directory

Browse clinical research sites, groups, and studies.

SitesGroupsStudies
Back to Studies
NOT YET RECRUITING
NCT07269392
PHASE4

Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo Transfer

Sponsor: National Taiwan University Hospital

View on ClinicalTrials.gov

Summary

Impact of dual trigger using recombinant human chorionic gonadotropin (HCG) and gonadotropin-releasing hormone (GnRH) agonist on thawed modified natural cycle outcomes: an open-label multi-center randomized controlled trial.

Official title: Impact of Dual Trigger Using Recombinant Human Chorionic Gonadotropin (HCG) and Gonadotropin-releasing Hormone (GnRH) Agonist on Thawed Modified Natural Cycle Outcomes: an Open-label Multi-center Randomized Controlled Trial.

Key Details

Gender

FEMALE

Age Range

25 Years - 44 Years

Study Type

INTERVENTIONAL

Enrollment

170

Start Date

2026-01-01

Completion Date

2029-12-31

Last Updated

2025-12-16

Healthy Volunteers

Yes

Conditions

In Vitro Fertilization (IVF)Embryo Transfer

Interventions

DRUG

GnRH agonist

GnRH agonist add to hcg for trigger